Drawing for QCSTEM

USPTO serial 79319041

QCSTEM

Reviewed by CopyMark Law Group

Reg. 6854637Status 700Registered
Filing date
Status date
Registration date
Sep 27, 2022
Examiner
HARMON, RAYMOND E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with QCSTEM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Todd A. Denys

Todd A. Denys Porzio, Bromberg & Newman, P.C.600 Alexander Road, Suite 2-1Princeton, NJ 08540UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for use in industry and science; biological preparation for use in cell cultures other than for medical or veterinary use; cell culture media for scientific and research use, not for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; stem cells for research purposes; stem cells for scientific purposes; nutritive agents for processing living cells other than for medical use; media for cell culture for laboratory use, other than medical useACTIVE—
009Scientific apparatus for cell culture systems, namely, cytometers and biomimetic 3D culture systems composed of cell culture dishes for cell culture systems; cultured cell apparatus for scientific use for analysis and sorting of cells, namely, laboratory pipettes and capsules for the analysis and sorting of cell culture; bioreactor for cell culturing; cultured cell observing apparatus; cell culture incubators; cell culture apparatus for laboratory use, namely, cell culture dishes and tissue culture flaks; software used for the collection, analysis, sorting, communication of biological information relating to stem cells; scientific apparatus for the analysis and sorting of cell culture, namely, laboratory pipettes and capsules for the analysis and sorting of cell culture; bioreactors for cell culture; observation apparatus for cell culture, namely, microscopes for cell culture; incubators for cell culture; cell culture apparatus for laboratory use, namely, cell culture dishes and tissue culture flasks; downloadable computer software used for the collection, analysis, sorting and communication of biological information relating to stem cellsACTIVE—
010apparatus for the regeneration of stem cells for medical purposes; apparatus for culture cell systems for medical use, namely cell culture chambers and capsules; apparatus for encapsulation of culture cell systems for medical use; cell culture apparatus for analysis and sorting of cells for medical useACTIVE—
041Publishing and issuing of scientific papers in the field of biotechnology and medical technology; publication of the results of clinical trials; publication of scientific information journals; publishing and issuing scientific papers in relation to biotechnologyACTIVE—
042Laboratory research in the field of biotechnology; scientific research on stem cells; scientific research on the production of pluripotent stem cells by encapsulation; research and development in the field of stem cells, cell and gene therapy and biotechnology; pharmaceutical research and development; scientific laboratory services; providing information with respect to scientific research in the field of stem cells, cell and gene therapy and biotechnologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 14, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 23, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 23, 2023FIMPFINAL DISPOSITION PROCESSED—
Dec 27, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 27, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 27, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 18, 2022GPNXNOTIFICATION PROCESSED BY IB—
Jul 12, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 12, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 29, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 29, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 22, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 6, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 6, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Jun 6, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 6, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 6, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
May 10, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 10, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 10, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2022RFNTREFUSAL PROCESSED BY IB—
Jan 29, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 28, 2022RFRRREFUSAL PROCESSED BY MPU—
Jan 8, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 7, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 5, 2022DOCKASSIGNED TO EXAMINER—
Sep 7, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 3, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 2, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance